"Doctors Are Legally BANNED From Telling You This" - Pharma Whistleblower | Brigham Buhler

Danny Jones
02:47:45 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (91)

0:07 Pharmaceutical Industry Whistleblower Background Story chapter 3
2:03 Pharmaceutical Industry and Healthcare System Critique
3:38 Critique of the US Healthcare System
5:15 Impact of Insurance on Primary Care
6:33 Pharmaceutical Industry's Impact on Healthcare System chapter 2
8:42 Pharmaceutical Industry Control of Healthcare
9:59 Pharmaceutical Industry Profit Motivations Exposed
11:26 Dark Side of Pharmaceutical Sales Tactics chapter 2
13:28 The Myth of Serotonin and Depression Treatment
15:02 Pharmaceutical Industry Influence on Medical Treatment
16:52 Pharmaceutical Industry Self-Regulation and Conflicts chapter 2
19:01 Pharmaceutical Industry's Influence on Medical Practices
20:44 Insurance Companies Limiting Medical Testing Options
22:13 Pharmaceutical Industry Cost Cutting and Profiteering chapter 2
24:13 Pharmaceutical Middlemen Price Fixing and Rebates
25:36 Pharmacy Benefit Managers' Impact on Healthcare
26:55 Conflict of Interest in Primary Care Ownership chapter 2
28:41 Problems with Modern Healthcare System
30:04 Benefits of Comprehensive Health Assessments
31:56 Neglecting Personal Health Consequences chapter 2
33:34 Declining Fertility Rates and Preventative Healthcare
35:04 Debunking Prostate Cancer Testosterone Treatment Myths
36:31 Challenging Medical Dogma on Testosterone and Cancer chapter 1
38:02 Pharmaceutical Industry Influence on Healthcare
40:47 Pharmaceutical Industry Approval Process and Insurance Coverage chapter 3
43:34 Insurance Companies' Manipulative Billing Practices
45:18 Breaking the Pharmaceutical Industry's Profit Cycle
47:16 Accessing Affordable and Convenient Medical Testing Options
48:43 Pharmaceutical Industry's Response to Grassroots Health Movement chapter 2
50:45 Pharmaceutical Industry Censorship and Corporate Capture
52:40 Pharmaceutical Price Gouging and Regulatory Abuse
54:30 Pharmaceutical Price Gouging and Regulation chapter 2
56:11 Pharmaceutical Industry Litigation and Regulatory Compliance
58:10 Pharmaceutical Industry Lobbying and Regulatory Influence
59:44 FDA Approval Process Criticized for Lack of Safety Studies chapter 2
1:01:40 Lack of Human Safety Studies in Medical Devices
1:03:07 Medical Device Safety and Regulatory Failures
1:04:51 Medical Device Failures and Patient Safety Risks chapter 3
1:07:36 Pharmaceutical Safety and Efficacy Variations
1:08:51 Pharmaceutical Industry's Role in Opioid Crisis
1:10:11 Pharmaceutical Industry Corruption and Regulatory Failures
1:11:35 Conflict of Interest in Pediatric Vaccine Schedules chapter 3
1:13:04 Hospital Systems Profit from Vaccine Sales
1:15:51 Vaccine Schedule and Parental Choice Concerns
1:17:20 Vaccine Industry Influence on Healthcare Providers
1:19:46 Financial Incentives in Medical Practice chapter 3
1:21:21 Medical Knowledge Obsolescence in Modern Healthcare
1:22:47 Pharmaceutical Industry Influence on Women's Health
1:24:32 Pharmaceutical Industry Manipulation and FDA Stance
1:27:31 Freedom of Choice in Healthcare Decisions chapter 2
1:29:03 Food Industry Corruption and Health Implications
1:30:51 Sugar Consumption Linked to Chronic Illness
1:32:08 Challenging Conventional Medicine and Healthcare Systems chapter 2
1:33:55 Benefits of Micro-Dosing GLP-1 Peptides
1:35:08 Benefits of Testosterone and Protein Synthesis
1:36:49 GLP-1 Medication Misuse and Ineffective Weight Loss chapter 1
1:39:00 Optimizing Hormones for Weight Loss and Health
1:40:49 Long-term Health Solutions Over Medication chapter 1
1:42:33 Patient Autonomy in Healthcare Decision Making
1:44:52 Maintaining Discipline in Health and Wellness chapter 3
1:46:15 Optimizing Health Through Nutrition and Education
1:47:33 Pharmaceutical Industry Corruption and Whistleblowing
1:48:59 Pharmaceutical Industry Lobbying and Healthcare Reform
1:51:01 Pharma Whistleblower Discusses FDA Leadership Changes chapter 1
1:52:51 Regulatory Pathways for Affordable Healthcare Options
1:55:51 Pharmaceutical Regulation and the Black Market chapter 1
1:58:04 Pharmaceutical Contamination and Regulatory Failures
2:00:52 Pharmaceutical Industry Obstruction of Alternative Treatments chapter 2
2:02:11 Risks of Unregulated Stem Cell and Peptide Treatments
2:03:46 Pharma Approval Process vs. Cash-Based Medicine
2:06:17 Affordability and Accessibility of Peptide Treatments chapter 2
2:08:27 Glyphosate Exposure and Cancer Rates Compared
2:10:00 Differences in Food Ingredients Across Countries
2:12:08 Glyphosate in Food and Regulatory Corruption chapter 3
2:13:36 Conflict of Interest in Pharmaceutical Industry
2:14:59 Stem Cell Banking and Its Viability
2:16:33 Risks of Unregulated Stem Cell Preservation
2:17:52 Experimental Medical Treatments and Unconventional Therapies chapter 3
2:20:02 Aging and Loss of Cellular Building Blocks
2:21:22 Regenerative Medicine and Cellular Therapy Explained
2:25:10 Potential of Muse Cells in Regenerative Medicine
2:27:16 Stem Cell Therapy for Alzheimer's and Dementia chapter 1
2:29:30 Regulatory Pathways for Alternative Medical Treatments
2:31:55 Emerging Biotechnology and Genetic Enhancements chapter 1
2:33:42 Unlocking the Secrets of Human Genome and Aging
2:36:17 Government Funding for Mind Control and Psychedelic Research chapter 1
2:38:34 Psychedelic Research and Industry Controversies
2:40:50 Pharma Funding and Psychedelic Research Opposition chapter 3
2:43:03 Psychedelic Research and Industry Backlash Concerns
2:44:20 Psychedelics and Religious Beliefs Amplification
2:45:31 Preventive Healthcare and Personal Autonomy

Transcript

Loading transcript...